Bod Science Limited is an Australia-based cannabis focused drug development and product...Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and the United States. The Company’s segments include Medical, Over the counter cannabidiol/Hemp (OTC CBD/Hemp), OTC Herbals, and Corporate. The Company also owns the Aqua Phase delivery technology. The technology delivers a GMP active pharmaceutical ingredient (API) or compound in dry form for use in products.More
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
ASX News
